← FDA Drug Approvals (Drugs@FDA)

CYTARABINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HOSPIRA · Approved 1999-11-22

Drug application

FDA Application #
ANDA075383
Application type
Abbreviated New Drug Application (Generic)
Brand name
CYTARABINE
Generic name
CYTARABINE
Active ingredients
CYTARABINE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
HOSPIRA
Manufacturer
Hospira, Inc.
First approval
1999-11-22

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown